Target intelligence / Profile preview

Glycosylphosphatidylinositol anchor attachment 1 protein (GPAA1)

Target
GPAA1
Molecular classification
Enzyme, Transamidase complex component, Membrane protein
01

Overview

Glycosylphosphatidylinositol anchor attachment 1 protein (GPAA1) is a core subunit of the GPI transamidase complex, which catalyzes the covalent attachment of a glycosylphosphatidylinositol (GPI) lipid anchor to specific proteins during post-translational modification in the endoplasmic reticulum. This process is essential for anchoring many proteins to the cell surface and is broadly required for normal cellular function. GPAA1 is a metallo-peptide-synthetase of the M28 family, likely binding a zinc ion, and helps form the structural and enzymatic core of the transamidase complex together with partners such as PIG-K and PIG-T[1][2][4]. The GPAA1 gene is ubiquitously expressed in human tissues, and mutations are linked to GPI biosynthesis defects causing congenital and neuromuscular disorders[4]. GPAA1 interacts closely with other GPI transamidase subunits, facilitating the transfer and covalent attachment of the GPI-anchor to the ω-site of substrate proteins[1][2][3][4]. There are no current therapeutic drugs or inhibitors directly targeting GPAA1 for clinical use, but its essential role in GPI-anchor biosynthesis makes it a potential target for future drug discovery, especially for infectious diseases involving GPI-anchored proteins[1].

Other names
GPI-anchor transamidase component GPAA1GPI anchor attachment protein 1GAA1hGAA1GPAA1P anchor attachment protein 1 homologGPI transamidase subunitGPIBD15glycophosphatidylinositol anchor attachment 1 protein
02

Biological functions

GPI anchor biosynthesisProtein post-translational modificationCell surface protein anchoring
03

Disease associations

Glycosylphosphatidylinositol biosynthesis defect (GPIBD15)Limb-girdle muscular dystrophyPossibly involved in rare congenital disorders of glycosylation
04

Safety considerations

Disruption can result in defective GPI-anchored protein expressionMay cause congenital disorders with neurological and muscular symptoms

Beyond the preview

Go deeper on Glycosylphosphatidylinositol anchor attachment 1 protein (GPAA1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycosylphosphatidylinositol anchor attachment 1 protein (GPAA1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call